Hillhouse Capital Leads $160M Series B Round In Genor Biopharma
June 2, 2020 — 12:16 CST
This Data Is Locked!
This area is available only to Subscribers.
Shanghai-based biopharmaceutical company Genor Biopharma has completed a US$160 million Series B round financing led by existing investor Hillhouse Capital. New investors in the round... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals